Target
Tyrosine-protein kinase JAK2 [Y1007F,Y1008F]
Ligand
BDBM607828
Substrate
n/a
Meas. Tech.
JAK2 Binding Assay
Kd
<10±n/a nM
Citation
 Masse, CEGreenwood, JRMondal, SXu, JGhanakota, PMcRobb, FMBoyles, N 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors US Patent  US11691963 Publication Date 7/4/2023 
Target
Name:
Tyrosine-protein kinase JAK2 [Y1007F,Y1008F]
Synonyms:
Tyrosine-protein kinase JAK2 (Y1007F, Y1008F)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
130652.68
Organism:
Homo sapiens (Human)
Description:
O60674[Y1007F,Y1008F]
Residue:
1132
Sequence:
MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM607828
Synonyms:
US11691963, Example I-6
Type:
Small organic molecule
Emp. Form.:
C22H19F2N5O2
Mol. Mass.:
423.4154
SMILES:
CC(=O)Nc1cc(Oc2ccc3nc(Nc4ccc(F)cc4F)n(C)c3c2C)ccn1
Structure:
Search PDB for entries with ligand similarity: